In general, biotech and life science companies [that list in Switzerland] benefit from a strong peer group and are helped by the fact that the listing…
In Conversation
Zurich was a good fit for EraCal’s novel platform idea. There is more room for error here and the Swiss ecosystem truly has fantastic initiatives to…
Bristol Myers Squibb has lent its full support to Saudi Arabia’s 2030 Strategic Vision, and we are happy to see that the pharma industry has been…
As a result of Turkey’s high-quality medical treatment, medical tourism is significantly increasing. Patients from all around the world, especially the Middle East, are coming to…
Switzerland wants to have its cake and eat it – paying less for healthcare without seeing a drop in quality. We are a rich country that…
US investment decides where to go for periods of 7-10 years, so Turkey has to be ready so as not to miss the window of opportunity…
Every crisis creates an opportunity and I believe that COVID showed us the importance of investing in R&D and the pharma sector to bring innovation
During the past 20 years, we have built clusters like Biopolis, universities and institutions and so on. The piece that we are doubling down is in…
We have leading products in diabetes, cardio, and fertility, neurology and are also very strong in oncology. It is not only about being number one in…
As we are able to now understand biological systems much better and leverage the countless advances in the technologies and tools that can enable us to…
Overall, the Swiss healthcare ecosystem in my mind is a fabulous basis to build upon
The capabilities that we have built for UPS healthcare as a result of the pandemic and the lessons learned will allow us to build a stronger…
